Elyse Katz is a seasoned professional in the field of translational medicine, currently serving as the Director of Translational Medicine at Alkermes since September 2025. Previously, Katz held the position of Project Manager at Tunnell Government Services, Inc., where responsibilities included leading a Phase 2/3 Adaptive Platform Trial for PTSD therapeutics and driving precision medicine strategies. Katz also has experience as a Senior Manager at Pfizer, focusing on genomic imaging in Alzheimer's disease, and as a Research Scientist at the Neuropsychiatric Institute - UCLA, analyzing neurobiological data related to Obsessive-Compulsive Disorder. Katz earned a PhD in Neuroscience from Emory University in 2008.
This person is not in any teams
This person is not in any offices